Skip to content

Effect of acupressure on dysmenorrhea

Comparison the effect of acupressure on third liver Point (liv.3) and sixth spleen point (SP.6) on pain intensity for patients with primary dysmenorrhea

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201201308869N1
Enrollment
105
Registered
2013-05-13
Start date
2012-05-09
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhoea. Primary dysmenorrhoea

Interventions

Intervention 1: Pressure on sp.6 acupressure point. The pressure is applied on both feet alternately as 2 minutes in the pressure point rotating clockwise and 2 minutes rest. Pressure will be applied
Pressure on sp.6 acupressure point. The pressure is applied on both feet alternately as 2 minutes in the pressure point rotating clockwise and 2 minutes rest. Pressure will be applied two times on eac
Pressure on Liv.3 acupressure point. The pressure is applied on both feet alternately as 2 minutes in the pressure point rotating clockwise and 2 minutes rest. Pressure will be applied two times on ea
Pressure on placebo point. The pressure is applied on both feet alternately as 2 minutes in the pressure point rotating clockwise and 2 minutes rest. Pressure will be applied two times on each leg and

Sponsors

Vice chancellor for research, Kashan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
17 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Being a student at the dormitory, being single, regularity of menses, start of Pain with the onset of menstrual bleeding, duration of bleeding between 3-8 days and Menstrual intervals of 21-35 days, pain with a score of at least 4 of 10 according to the V.A.S. criteria in most menstrual cycles, lack of pain throughout the all times of menstrual cycle or bleeding, lack of anemia, high blood pressure, Psychiatric disorders especially depression (19 points or more, according to the beck-21 criteria for depression), lack of any known disease of genital tract, secondary dysmenorrhea, no history of abdominal or pelvic surgery, not using tobacco (cigarettes, hookah and drugs) and alcohol, disorders of speech and hearing, mental, heart and renal disorders, respiratory disease, diabetes, asthma, hypothyroidism or hyperthyroidism, severe psychological stress in the past 6 months (e.g., family death, surgery, marriage, separation of parents), lack of voluntary weight loss, absence of any problems in the pressure point such as fractures, ulcers, varicose veins, skin disease or inflammation, specific dietary regimen such as vegetarianism, eating raw, high salt or carbohydrates intake. Exclusion criteria: Use of heat, oral contraceptives or drugs that can affect on ovulation cycle, non steroidal anti-inflammatory, analgesic, Prostaglandins synthesis inhibitors for 4 hours before till 4 hours after applying pressure, not continue to cooperate until the end of the study (3 cycles).

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain intensity. Timepoint: Pain intensity in the first cycle at the onset of bleeding and half, one, two and three hours after the onset of bleeding. Pain intensity in the second cycle at the onset of bleeding and half, one, two and three hours after the onset of bleeding. Pain intensity in the third cycle at the onset of bleeding and half, one, two and three hours after the onset of bleeding. Method of measurement: Visual analog scale of pain intensity.

Secondary

MeasureTime frame
Quality of life. Timepoint: Before intervention (first cycle) and after intervention (third cycle). Method of measurement: Quality of life questionnaire (WHOQOL-BREF-26).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahboobeh Kafaei Atrian

Kashan University of Medical Sciences

kafaei_m@kaums.ac.ir+98 36 1555 0021

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026